Predict your next investment


See what CB Insights has to offer

Founded Year



Acquired | Acquired

Total Raised


About ClariFI

ClariFI was a Software (non-internet/mobile) company based in New York, New York. ClariFI was acquired in 2007.

ClariFI Headquarter Location

55 Water Street 49th Floor

New York, New York, 10041,

United States


Latest ClariFI News

Modulim Granted CE Mark for Clarifi Imaging System for Microvascular Assessment

Jan 4, 2021

Modulim Granted CE Mark for Clarifi Imaging System for Microvascular Assessment Clarifi is the newest advancement for assessing tissue and microvascular function. Business Wire01.04.21 Modulim , the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced that Clarifi has received CE Mark certification. This allows Modulim to now expand its marketing and distribution throughout Europe and apply for registration in other international markets that recognize the CE Mark. Powered by Spatial Frequency Domain Imaging (SFDI), a patented optical imaging technology,  Clarifi  is the newest advancement for assessing tissue and microvascular function by quantitatively mapping tissue oxygenation and perfusion at the point-of-care. Clarifi’s fully-integrated solution is rapidly gaining acceptance by clinicians across the continuum of care for assessing potential circulatory compromise to manage and treat diabetic, venous and pressure ulcers, acute and chronic wounds, burns, and amputations. “Obtaining CE marking for the Clarifi Imaging System is a key milestone for Modulim,” said David Cuccia, Ph.D., Modulim’s president and chief technology officer. “This achievement allows us to expand our addressable market and deliver a complete microvascular assessment solution that helps clinicians prevent lower limb complications in patients with diabetes as well as other life-altering circulatory issues. We are now able to bring our innovative technology to our European clinical partners, and grow our ever expanding image library by reaching the 60 million diabetes patients in the EU.”   Clarifi can help clinicians identify potential compromised circulation and pre-ulcerative conditions, before they are visible, so they can implement timely and targeted intervention to prevent costly and deadly complications. Powered by SFDI, Clarifi provides new information that enables healthcare providers in all environments to transition from reactive care to proactive care. The Clarifi Imaging System demonstrates Modulim’s continuing mission to deliver transformative optical solutions that help people live healthier, longer lives. PR Newswire 01.04.21 GlobalData 01.04.21 Edwards Lifesciences Corp. 12.21.20 Martin-Luther-Universität Halle-Wittenberg 12.18.20 Royal Philips 12.18.20 PR Newswire 12.18.20 Molex 12.18.20 CM&B Inc. 12.17.20 U.S. Food and Drug Administration 12.17.20 PR Newswire 12.16.20 4D Biomaterials 12.16.20 Business Wire 12.16.20 U.S. Food and Drug Administration 12.16.20 iRhythm Technologies Inc. 12.16.20 PR Newswire 12.16.20

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.